跳到正文
Generate:Biomedicines· @generate_biomed · X·· 7 天前AI 评分28
AI 导读

Generate Biomedicines 借助 Anthropic 的 Claude 推进 CAR-T 细胞研究,CEO Mike Nally 称用 Claude 缩短 CAR-T 细胞引擎存在巨大机会。其路径是把自研蛋白质生成模型、结合 Claude 等 LLM 智能体的生物学模型与科学专家组成“trifecta”,共同加速药物开发流程。

正文 · 原文

Where do AI agents fit in drug development?

In @FierceBiotech, @marissarussoo explores @Anthropic’s growing role in drug research through our CAR T-cell work. @mike_nally, our CEO, discusses the opportunity, and @KaggenA, our vice president of application development, explains the “trifecta” behind the science. Our own protein-generation models, biology models with LLM agents such as Claude, and scientific experts working together to accelerate the process.

Read “Generate CEO sees huge opportunity from using Claude to shorten CAR-T cell engines” → https://www.fiercebiotech.com/research/anthropic-extends-its-biological-footprint-generates-car-t-cells

来源:Generate:Biomedicines · x.com